<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A middle-aged woman began experiencing spells of profound <z:e sem="disease" ids="C0233795" disease_type="Mental or Behavioral Dysfunction" abbrv="">anterograde amnesia</z:e> several months after beginning intrathecal <z:chebi fb="0" ids="2972">baclofen</z:chebi> treatment for <z:hpo ids='HP_0007325'>generalized dystonia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Her spells met criteria for <z:hpo ids='HP_0010534'>transient global amnesia</z:hpo>, but were unusual because of their frequent recurrence and because their frequency was somewhat dose-dependent on <z:chebi fb="0" ids="2972">baclofen</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="50885">Fludrocortisone</z:chebi> decreased the frequency of these episodes, and sublingual <z:chebi fb="0" ids="28787">nitroglycerin</z:chebi> both prevented and terminated them </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="2972">Baclofen</z:chebi>-induced <z:e sem="disease" ids="C0002622" disease_type="Mental or Behavioral Dysfunction" abbrv="">amnesia</z:e> in rodents is a reliable model of <z:hpo ids='HP_0002354'>memory impairment</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast, <z:chebi fb="0" ids="2972">baclofen</z:chebi>-induced <z:hpo ids='HP_0002354'>memory impairment</z:hpo> in humans is uncommon </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="2972">Baclofen</z:chebi>- associated <z:hpo ids='HP_0010534'>transient global amnesia</z:hpo> has not previously been reported </plain></SENT>
</text></document>